Skip to main content
Annals of Medicine logoLink to Annals of Medicine
letter
. 2025 Jul 15;57(1):2534524. doi: 10.1080/07853890.2025.2534524

Regarding: nailfold capillary abnormalities as indicators of diabetic nephropathy progression: a cross-sectional study in type 2 diabetes

Jingyuan Ma a, Wenxing Fan a,b,
PMCID: PMC12265087  PMID: 40662730

To the Editor

We read with great interest the recent article titled “Nailfold capillary abnormalities as indicators of diabetic nephropathy progression: a cross-sectional study in type 2 diabetes” published in Annals of Medicine [1]. The authors should be commended for providing a comprehensive analysis of nailfold videocapillaroscopy (NVC) as a non-invasive biomarker for diabetic nephropathy (DN) progression. The innovative integration of KDIGO staging with capillary morphological data, along with the development of a semi-quantitative NVC scoring system, highlights the potential of this technique for early microvascular assessment and personalized risk stratification in type 2 diabetes.

Despite its strengths, we believe that several important limitations deserve attention to strengthen future investigations in this area. First, although the study controlled for some metabolic parameters, it did not account for non-renal microvascular complications (such as diabetic retinopathy [2] or neuropathy [3]) that may independently alter NVC results. Given the shared pathophysiological basis across these complications, future studies should include stratified analyses or multivariate adjustments to isolate DN-specific microvascular changes.

Second, the reproducibility and objectivity of NVC assessments remain a concern. While the authors performed all examinations by a single trained operator, the lack of inter-rater validation or AI-based image quantification may limit the generalizability of findings. We suggest future work incorporate blinded dual-assessor validation or explore machine learning tools for automated capillary analysis to standardize interpretation and facilitate clinical translation. Third, the study did not evaluate the incremental predictive value of NVC beyond conventional DN markers such as eGFR and albuminuria [4]. Incorporating ROC analysis, net reclassification improvement (NRI), or decision curve analysis could demonstrate whether NVC adds clinical utility in risk prediction models and helps guide decision-making in real-world settings.

In the context of the global rise of chronic diseases like diabetes, it is critical that national public health systems integrate predictive tools like NVC within a tiered emergency management framework and broader preventive health networks. The inclusion of NVC screening into community health check-ups could align with primary-level risk identification strategies, especially in resource-limited settings. Moreover, health policy should incentivize multidisciplinary models where endocrinologists, nephrologists, and community-based chronic disease managers collaborate using tools like NVC for early-stage intervention.

In conclusion, this article provides valuable insights into the microvascular pathophysiology of DN and supports the potential of NVC as a novel screening and monitoring modality. Our comments aim to enhance the translational impact of this promising technique. We look forward to future research validating its predictive value longitudinally and integrating it into comprehensive chronic disease management systems.

Funding Statement

This work was supported by a grant from Reserve Talents Project for Young and Middle-aged Academic and Technical Leaders of Yunnan Province (Project Number: 202205AC160062), Yunnan Key Laboratory of Organ Transplantation (202449CE340016), “ChengFeng” Talent Training Project for Young and Middle-aged Academic Leaders and Reserve Talents of Kunming Medical University, and First-Class Discipline Team of Kunming Medical University (Project Number: 2024XKTDPY03).

Acknowledgements

All authors contributed to the study conception and design. Study design, JYM, Writing-original draft, JYM; Writing-review & editing, JYM, WXF; Supervision: WXF.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability

Data sharing is not applicable to this article as no data were created or analysed in this study.

References

  • 1.Hsu PC, Liao PY, Huang SW, et al. Nailfold capillary abnormalities as indicators of diabetic nephropathy progression: a cross-sectional study in type 2 diabetes. Ann Med. 2025;57(1):2458766. doi: 10.1080/07853890.2025.2458766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Uyar S, Balkarlı A, Erol MK, et al. Assessment of the relationship between diabetic retinopathy and nailfold capillaries in type 2 diabetics with a noninvasive method: nailfold videocapillaroscopy. J Diabetes Res. 2016;2016:7592402–7592407. doi: 10.1155/2016/7592402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Łukasik U, Bartosińska J, Kosior-Jarecka E, et al. Results of nailfold videocapillaroscopy in patients with pseudoexfoliative glaucoma. Life (Basel). 2023;13(4):967. Published 2023 Apr 7. doi: 10.3390/life13040967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Levey AS, Gansevoort RT, Coresh J, et al. Change in albuminuria and gfr as end points for clinical trials in early stages of ckd: a scientific workshop sponsored by the national kidney foundation in collaboration with the us food and drug administration and european medicines agency. Am J Kidney Dis. 2020;75(1):84–104. doi: 10.1053/j.ajkd.2019.06.009. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing is not applicable to this article as no data were created or analysed in this study.


Articles from Annals of Medicine are provided here courtesy of Taylor & Francis

RESOURCES